PN 400 (VIMOVO)

DRUG3 trials

Sponsors

POZEN

Conditions

Gastric UlcerOsteoarthritis

Phase 3

A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

CompletedNCT00527904

POZENGastric Ulcer

Start: 2007-03-31End: 2009-03-31Updated: 2010-08-31

Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis

CompletedNCT00664560

POZENOsteoarthritis

Start: 2008-04-30End: 2009-01-31Updated: 2012-02-27

Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis

CompletedNCT00665431

POZENOsteoarthritis

Start: 2008-04-30End: 2009-01-31Updated: 2011-12-06

Related Papers

Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib

The Physician and Sportsmedicine2015-07-0316 citations

Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials.

2011-04-2835 citations

Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers.

2011-02-1413 citations